Royalty Report: Drugs, Cancer, Disease – Collection: 329711

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Cancer
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 329711

License Grant
University hereby grants and Licensee accepts an exclusive license to Licensee under the Licensed Patent Rights and Licensed Know-How in the Licensed Territory to make, have made, use, offer for sale, sell, export, and import any Licensed Products in the Licensed Fields of Use and to practice and have practiced any Licensed Processes in the Licensed Fields of Use.
License Property
These patent rights include, but are not limited to, those rights in PCT Patent Application #WO 99/49870 “Vitamin D and its Analogs in the Treatment of Tumors and Other Hyperproliferative Disorders” and other patent applications related to the pulsatile high-dose administration of Vitamin D and analogs in tumors and other hyperproliferative disorders, including, but not limited to those listed

US Patent #6,521,608 – Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders

Field of Use
Licensed Fields of Use means all prophylactic, therapeutic, and diagnostic uses in humans and/or animals.

IPSCIO Record ID: 279315

License Grant
University grants an exclusive license under the Licensed Patent Rights in the Licensed Territory to make, have made, use, offer for sale, sell and import any Licensed Products in the Licensed Fields of Use and to practice and have practiced any Licensed Processes in the Licensed Fields of Use.
License Property
Inventions were conceived which relate to Vitamin D and its analogs in oncology and other disease therapies.

The patents are for Vitamin D and its Analogs in the Treatment of Tumors and Other Hyperproliferative Disorders, and, Patent applications related to the pulsatile high-dose administration of Vitamin D and analogs in tumors and other hyperproliferative disorders.

Field of Use
The Licensed Fields of Use means for all uses related to oncology and other disease therapies.

IPSCIO Record ID: 291191

License Grant
University hereby grants to Licensee a worldwide sole and exclusive license under the Patent Rights and Know-How to make, have made, use, import, export, offer for sale and sell the Licensed Products.
License Property
Patent Rights shall mean the interest of University in

(a)
the United States and foreign patents and/or patent applications listed;

(b)
United States and foreign patents issued from the applications listed and from divisionals, continuations and continuations-in-part of these applications;

(c)
claims of U.S. and foreign continuation-in-part applications, and of the resulting patents, which are directed to subject matter specifically described in the U.S. and foreign applications listed; and

(d)
claims of all foreign patent applications, and of the resulting patents, which are directed to subject matter specifically described in the United States patents and/or patent applications described in (a), (b) or (c) above.

6,087,350 – Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
6,559,139 – Combination chemotherapy

Licensed Product shall mean Vitamin D and one or more cytotoxic agents administered or otherwise used or offered for use in a manner which would, but for the license granted herein, infringe one or more of the Patent Rights.

Vitamin D shall mean cholecalciferol, as well as all derivatives and analogs thereof or thereto.

Field of Use
One of the issued U.S. patents claims a method of killing cells such as cancer cells with any vitamin D derivative together with paclitaxel or cyclophosphamide. The second issued patent claims a method of killing neoplastic cells with any vitamin D derivative together with  carboplatin, cisplatin, paclitaxel or Taxotere.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.